ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma

por Qu, Tongyuan, Zhang, Wenshuai, Yan, Chenhui, Ren, Danyang, Wang, Yalei, Guo, Yuhong, Guo, Qianru, Wang, Jinpeng, Liu, Liren, Han, Lei, Li, Lingmei, Huang, Qiujuan, Cao, Lu, Ye, Zhaoxiang, Zhang, Bin, Zhao, Qiang, Cao, Wenfeng
Publicado 2023

ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression

por Qu, Tongyuan, Zhang, Wenshuai, Qi, Lisha, Cao, Lu, Liu, Changxu, Huang, Qiujuan, Li, Guangning, Li, Lingmei, Wang, Yalei, Guo, Qianru, Guo, Yuhong, Ren, Danyang, Gao, Yanan, Wang, Jinpeng, Meng, Bin, Zhang, Bin, Cao, Wenfeng
Publicado 2020

A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma

por Huang, Qiujuan, Qu, Tongyuan, Qi, Lisha, Liu, Changxu, Guo, Yuhong, Guo, Qianru, Li, Guangning, Wang, Yalei, Zhang, Wenshuai, Zhao, Wei, Ren, Danyang, Sun, Leina, Wang, Shengguang, Meng, Bin, Sun, Baocun, Zhang, Bin, Ma, Wenjuan, Cao, Wenfeng
Publicado 2021